𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of anti-tumour necrosis factor agents in inflammatory bowel disease

✍ Scribed by S. Schreiber; M. Campieri; J.F. Colombel; S.J.H. van Deventer; B. Feagan; R. Fedorak; A. Forbes; M. Gassull; J.P. Gendre; R.A. van Hogezand; R. Lofberg; R. Modigliani; F. Pallone; W. Petritsch; C. Prantera; D. Rampton; F. Seibold; M. Vatn; M. Zeitz; P. Rutgeerts

Publisher
Springer
Year
2001
Tongue
English
Weight
54 KB
Volume
16
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver diseases associated with anti-tumo
Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-Ξ±) use for inflammatory bowel disease
✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha

Nonadherence in inflammatory bowel disea
Nonadherence in inflammatory bowel disease: Results of factor analysis
✍ Petr ČervenΓ½; Martin BortlΓ­k; AleΕ‘ KubΔ›na; JiΕ™Γ­ Vlček; Peter Laszlo Lakatos; Mil πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Background: The purpose of the study was to assess overall nonadherence to treatment among patients with crohn's disease (cd) and ulcerative colitis (uc) in a single tertiary center. ## Methods: A total of 177 patients were enrolled in this study (84 males, 93 females; 117 cd, 60 uc). patients

Differences in the incidence of flares o
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor Ξ± agents
✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co